6 completed, 2 recruiting, 2 withdrawn, 1 unknown. 2 Not applicable, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Withdrawn 1 |
Follow White Dot Syndromes: new trials by email Literature Review of White Dot Syndromes trials Research Report on White Dot Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quantification & Classification of Inflammatory Cells in Uveitis Using OCT Anterior Uveitis (AU), Birdshot Chorioretinitis | Recruiting | Oregon Health and Science University | 125 | 2024-09-01 | 2025-07-17 | |
| A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease Companion blood samples with procedure - Autoimmune Diseases, Ulcerative Colitis | Completed | TScan Therapeutics, Inc. | 238 | 2023-01-03 | 2026-09-15 | |
| PIC and Its Role in Progression of Pathological Myopia Punctate Inner Choroidopathy | Unknown | Assiut University | 39 | 2020-10-15 | 2021-06-18 | |
| Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis Bevacizumab - Punctate Inner Choroidopathy | Completed | Changhua Christian Hospital | 14 | 2018-10-01 | 2019-04-01 | |
| Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor Bevacizumab Injection - Choroidal Neovascularization, Punctate Inner Choroidopathy | Completed | Changhua Christian Hospital | 22 | 2018-03-13 | 2019-01-08 | |
| Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet- Rich Plasma Electromagnetic stimulation, Platelet rich plasma - Deep Retinal Capillary Ischemia, Paracentral Acute Middle Maculopathy | Not applicable | Completed | Ankara Universitesi Teknokent | 28 | 2018-01-01 | 2020-01-27 |
| Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD Bevacizumab (Avastin; Genentech, Inc.), Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy - Choroidal Neovascularization, Myopia | Not applicable | Withdrawn | Massachusetts Eye and Ear Infirmary | 2010-08-01 | 2014-01-14 | |
| Safety and Efficacy of AIN457 in Noninfectious Uveitis AIN457, AIN 457 - Non-infectious Uveitis | Phase 2 | Completed | Novartis Pharmaceuticals | 76 | 2008-06-01 | 2017-07-17 |
| Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a interferon alpha 2a, prednisone - Birdshot Chorioretinopathy, Cystoid Macular Edema | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 58 | 2007-09-01 | 2013-01-23 |
| Intravitreal Bevacizumab for Inflammatory Neovascular Membranes Bevacizumab, Intravitreal Injection of Bevacizumab - Vogt Koyanagi Harada Disease, Serpiginous Choroiditis | Phase 3 | Withdrawn | Asociación para Evitar la Ceguera en México | 2006-12-01 | 2024-05-30 | |
| Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD) Observational study - Birdshot Chorioretinopathy, Posterior Uveitis | Recruiting | Assistance Publique - Hôpitaux de Paris | 600 | 2004-11-02 | 2026-03-04 |
Birdshot Chorioretinopathy (5) · Multifocal Choroiditis (4) · Behcet Syndrome (2) · Choroidal Neovascularization (2) · Sarcoidosis (2) · Uveitis (2) · Uveitis, Posterior (2) · Angioid Streaks (1) · Arthritis, Juvenile (1) · Autoimmune Diseases (1) · Celiac Disease (1) · Central Serous Chorioretinopathy (1) · Colitis, Ulcerative (1) · Eye Diseases, Hereditary (1)
Eye Diseases (11) · Uveal Diseases (11) · Panuveitis (10) · Choroid Diseases (9) · Uveitis (9) · Uveitis, Posterior (9) · Choroiditis (8) · Immune System Diseases (6) · Retinal Diseases (6) · Autoimmune Diseases (5) · Chorioretinitis (5) · Retinitis (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3)
Bevacizumab (4) · Dexamethasone (1) · Interferon alpha-2 (1) · Observation (1) · Prednisone (1) · secukinumab (1)
Assistance Publique - Hôpitaux de Paris (2) · Changhua Christian Hospital (2) · Ankara Universitesi Teknokent (1) · Asociación para Evitar la Ceguera en México (1) · Assiut University (1) · Massachusetts Eye and Ear Infirmary (1) · Novartis Pharmaceuticals (1) · Oregon Health and Science University (1) · TScan Therapeutics, Inc. (1)
United States (3) · France (2) · Taiwan (2) · Germany (1) · Japan (1) · Mexico (1) · Turkey (Türkiye) (1)
Ehab Is Wasfi, As prof (1) · Ivana K Kim, MD (1) · Kyoko Oh Matsui, Prof (1) · LuzElena Concha-Del Rio, MD (1) · Mahmoud Fa Rateb, As prof (1) · Omar Mo Ali, Prof (1) · Shymaa Kl Hady, As Lec (1) · Umut Arslan, MD (1) · Veronica Kon-Jara, MD (1) · Yan Li, PhD (1)
PMID 15079763, PMID 20926833, PMID 25638011, PMID 31385285, PMID 37204866, PMID 39250617, PMID 40010761, PMID 40522203
R21EY036563 (1)